Many companies make development plans based on the shortest path to filing a marketing application. This may mean doing the minimum number of trials required to gain approval and designing trials to maximize the probability of gaining a positive clinical outcome. This panel will describe and discuss an alternative approach. By understanding the promotional claims necessary for successful commercialization before pivotal trials are initiated and by involving all the relevant regulatory disciplines in designing a development program, the probability of commercial success can be maximized.